Daptomycin may be a feasible treatment option for patients with Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection when vancomycin MICs are 1.5-2.0 μg/mL.
HIV Prophylaxis with twice-daily lopinavir/ritonavir was well tolerated in high-risk neonates without adverse drug events, as reported at IDWeek 2013.
Girls 9-13 years with HIV who received the quadrivalent human papillomavirus vaccine (qHPV) had significantly lower peak geometric mean titers (GMT) vs. same-aged girls without HIV infection, a study presented at IDWeek 2013 has found.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Introduction of a universal varicella vaccine program for U.S. children in 1996 has not correlated with a significant increase in herpes zoster incidence in older U.S. adults.
Individuals infected with a recombinant strain of HIV have a higher risk of developing and dying of AIDS, and developing and dying from AIDS sooner than individuals infected with either parent strain.
Cells that remain infected with HIV even after antiretroviral treatment can be effectively killed with a radiolabeled antibody targeting HIV infected cells, including cells in the brain.
The FDA has designated isavuconazole (Astellas Pharma) a Qualified Infectious Disease Product (QDIP) for the treatment of invasive aspergillosis.
LabCorp announced the availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80k polymorphism.
The goal of this program is to improve the management of office emergencies.2.00 AMA PRA Category 1 Credit(s)TM
This slide/audio program, narrated by Camille Kotton, MD, Massachusetts General Hospital, will provide the learner with updated relevant ...1.00 AMA PRA Category 1 Credit(s)TM
This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and ...1.00 AMA PRA Category 1 Credit(s)TM